Study identifier:D133HR00044
ClinicalTrials.gov identifier:NCT07143110
EudraCT identifier:N/A
CTIS identifier:N/A
LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada
Lung Neoplasms
N/A
No
-
All
60000
Observational
18 Years - 130 Years
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Aug 2025 by AstraZeneca
AstraZeneca
-
No locations available
| Arms | Assigned Interventions |
|---|---|
| Non-Small Cell Lung Cancer (NSCLC) | - |
| Small Cell Lung Cancer (SCLC) | - |